Mga Batayang Estadistika
| LEI | 549300SNASESIFOS6V75 |
| CIK | 805267 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Abrdn Healthcare Investors
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| April 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission |
|
| November 18, 2024 |
HQH / Abrdn Healthcare Investors / Saba Capital Management, L.P. - FORM SC 13D/A Activist Investment SC 13D/A 1 formsc13da.htm FORM SC 13D/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 3)* abrdn Healthcare Investors (Name of Issuer) Common Shares, $0.01 par value (Title of Class of Securities) 87911J103 (CUSIP Number) Saba Capital Management, L.P. 405 Lexington Avenue 58th Floor New York, NY 10174 |
|
| October 22, 2024 |
HQH / Abrdn Healthcare Investors / Saba Capital Management, L.P. - FORM SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 2)* abrdn Healthcare Investors (Name of Issuer) Common Shares, $0.01 par value (Title of Class of Securities) 87911J103 (CUSIP Number) Saba Capital Management, L.P. 405 Lexington Avenue 58th Floor New York, NY 10174 Attention: Michael D'Angelo (212) 542-46 |
|
| May 3, 2024 |
HQH / Abrdn Healthcare Investors / Saba Capital Management, L.P. - FORM SC 13D/A Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D/A Under the Securities Exchange Act of 1934 (Amendment No. 1)* abrdn Healthcare Investors (Name of Issuer) Common Shares, $0.01 par value (Title of Class of Securities) 87911J103 (CUSIP Number) Saba Capital Management, L.P. 405 Lexington Avenue 58th Floor New York, NY 10174 Attention: Michael D'Angelo (212) 542-46 |
|
| April 22, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission |
|
| March 15, 2024 |
HQH / Abrdn Healthcare Investors / Saba Capital Management, L.P. - FORM SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No.)* abrdn Healthcare Investors (Name of Issuer) Common Shares, $0.01 par value (Title of Class of Securities) 87911J103 (CUSIP Number) Saba Capital Management, L.P. 405 Lexington Avenue 58th Floor New York, NY 10174 Attention: Michael D'Angelo (212) 542-4635 ( |
|
| March 15, 2024 |
JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k) EX-1 2 exhibit1.htm EXHIBIT 1 EXHIBIT 1 JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k) The undersigned acknowledge and agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13D shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agree |
|
| October 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| October 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| October 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| September 27, 2023 |
As filed with the Securities and Exchange Commission on September 27, 2023 As filed with the Securities and Exchange Commission on September 27, 2023 Securities Act File No. |
|
| September 27, 2023 |
BY-LAWS H&Q HEALTHCARE INVESTORS Revised through June 8, 2023 ARTICLE I Exhibit (b) BY-LAWS - OF - H&Q HEALTHCARE INVESTORS - Revised through June 8, 2023 ARTICLE I - Definitions - The terms "Commission," "Custodian," "Declaration," "Distributor," "Investment Adviser," "Majority Shareholder Vote," "1940 Act," "Shareholder," "Shares," "Transfer Agent," "Trust," "Trust Property" and "Trustees" have the respective meanings given them in the Declaration of Trust of H&Q Healthcare Fund dated October 31, 1986 as amended from time to time. |
|
| September 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| September 15, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| September 13, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| September 12, 2023 |
Exhibit 16.1 September 12, 2023 Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-7561 Dear Sirs/Madams: We have read Item 4.01 of Tekla Healthcare Investors’ Form 8-K dated September 12, 2023, and we agree with the statements made therein. Yours truly, Deloitte & Touche LLP 200 Berkeley Street Boston, MA 02116 USA Tel: 617-437-2625 Fax: 617-437-4625 www.deloitte.com |
|
| September 12, 2023 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported): September 12, 2023 (September 6, 2023) Tekla Healthcare Investors (Exact name of Registrant as Specified in Its Charter) Massachusetts 811-04889 04-6564285 (State or other jurisdictio |
|
| September 5, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| August 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| August 22, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| August 22, 2023 |
Tekla Healthcare Investors Tekla Life Sciences Investors Tekla Healthcare Opportunities Fund Tekla World Healthcare Fund August 22, 2023 Via EDGAR Mindy Rotter U. |
|
| August 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| August 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| July 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| July 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| July 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| July 10, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defin |
|
| June 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: x Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| April 11, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| February 24, 2023 |
Tekla Healthcare Investors SCHEDULE OF INVESTMENTS December 31, 2022 NPORT-EX 2 NPORTTN00643264901222.htm Tekla Healthcare Investors SCHEDULE OF INVESTMENTS December 31, 2022 (Unaudited) SHARES CONVERTIBLE PREFERREDS (Restricted)(a)(b) – 7.1% of Net Assets VALUE Biotechnology – 4.4% 82,076 Arbor Biotechnologies Series B, 8.00% $ 1,359,999 2,353,932 Arkuda Therapeutics, Inc. Series A, 6.00% (c) 4,162,222 487,526 Arkuda Therapeutics, Inc. Series B, 6.00% (c) 862,043 |
|
| August 26, 2022 |
Tekla Healthcare Investors SCHEDULE OF INVESTMENTS June 30, 2022 (Unaudited) NPORT-EX 2 NPORTTN00938351920622.htm Tekla Healthcare Investors SCHEDULE OF INVESTMENTS June 30, 2022 (Unaudited) SHARES Convertible Preferred (Restricted) (a)(b) – 7.7% of Net Assets VALUE Biotechnology – 4.8% 326,667 Amphivena Therapeutics, Inc. Series B (c) $ 33 525,972 Amphivena Therapeutics, Inc. Series C, 6.00% (c) 53 82,076 Arbor Biotechnologies, Series B, 8.00% 1,359,999 2,353,932 Arkuda T |
|
| July 29, 2022 |
As filed with the Securities and Exchange Commission on July 29, 2022 As filed with the Securities and Exchange Commission on July 29, 2022 Securities Act File No. |
|
| July 29, 2022 |
Notice of Change of Trustee, filed herewith Exhibit (a)(xvii) TEKLA HEALTHCARE INVESTORS Amendment to Declaration of Trust Notice of Change of Trustee WHEREAS, upon the death of Oleg M. |
|
| July 1, 2022 |
As filed with the Securities and Exchange Commission on July 1, 2022 As filed with the Securities and Exchange Commission on July 1, 2022 Securities Act File No. |
|
| July 1, 2022 |
Power of Attorney dated June 9, 2022(15) Exhibit (n)(ii) POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that W. Mark Watson, whose signature appears below, constitutes and appoints Daniel R. Omstead, Laura Woodward, Christopher Harvey and Kaitlin McGrath and each of them, his or her true and lawful attorney-in-fact and agent, with full power of substitution among himself or herself and each of the persons appointed herein, for him |
|
| July 1, 2022 |
Notice of Change of Trustee, dated June 16th, 2022(15) Exhibit (a)(xvi) TEKLA HEALTHCARE INVESTORS Amendment to Declaration of Trust Notice of Change of Trustee WHEREAS, at a meeting of the shareholders of Tekla Healthcare Investors (the ?Fund?), the shareholders of the Fund appointed W. |
|
| April 12, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ? Defin |
|
| February 23, 2022 |
Tekla Healthcare Investors SCHEDULE OF INVESTMENTS December 31, 2021 Tekla Healthcare Investors SCHEDULE OF INVESTMENTS December 31, 2021 (Unaudited) SHARES CONVERTIBLE PREFERRED (Restricted)(a) (b) – 5. |
|
| December 22, 2021 |
Power of Attorney dated November 30, 2021(14) Exhibit (n)(ii) POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that Kathleen L. |
|
| December 22, 2021 |
Notice of Change of Trustee, dated December 13, 2021(14) Exhibit (a)(xv) TEKLA HEALTHCARE INVESTORS Amendment to Declaration of Trust Notice of Change of Trustee WHEREAS, by Action of Written Consent, the Trustees of Tekla Healthcare Investors (?The Fund?), the Trustees of the Fund appointed Kathleen L. |
|
| December 22, 2021 |
As filed with the Securities and Exchange Commission on December 22, 2021 POS EX 1 tm2134557d1posex.htm POS EX As filed with the Securities and Exchange Commission on December 22, 2021 Securities Act File No. 333-195327 Investment Company Act File No. 811-04889 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM N-2 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 x Pre-Effective Amendment No. Post-Effective Amendment No. 8 REGISTRATION S |
|
| August 26, 2021 |
Tekla Healthcare Investors SCHEDULE OF INVESTMENTS June 30, 2021 Tekla Healthcare Investors SCHEDULE OF INVESTMENTS June 30, 2021 (Unaudited) SHARES CONVERTIBLE PREFERRED (Restricted) (a)(b) – 5. |
|
| July 2, 2021 |
Notice of Change of Trustee, dated June 16, 2021(13) Exhibit (a)(xiv) TEKLA HEALTHCARE INVESTORS Amendment to Declaration of Trust Notice of Change of Trustee WHEREAS, Lucinda H. |
|
| July 2, 2021 |
As filed with the Securities and Exchange Commission on July 2, 2021 As filed with the Securities and Exchange Commission on July 2, 2021 Securities Act File No. |
|
| April 13, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| February 26, 2021 |
TEKLA HEALTHCARE INVESTORS SCHEDULE OF INVESTMENTS DECEMBER 31, 2020 TEKLA HEALTHCARE INVESTORS SCHEDULE OF INVESTMENTS DECEMBER 31, 2020 SHARES VALUE CONVERTIBLE PREFERRED AND WARRANTS (Restricted)(a) (b) - 4. |
|
| January 5, 2021 |
As filed with the Securities and Exchange Commission on January 5, 2021 Securities Act File No. |
|
| January 5, 2021 |
By-Laws of the Registrant, as amended(12) Exhibit (b) BY-LAWS OF H&Q HEALTHCARE INVESTORS Revised through December 10, 2020 ARTICLE I Definitions The terms "Commission," "Custodian," "Declaration," "Distributor," "Investment Adviser," "Majority Shareholder Vote," "1940 Act," "Shareholder," "Shares," "Transfer Agent," "Trust," "Trust Property" and "Trustees" have the respective meanings given them in the Declaration of Trust of H&Q Healthcare Fund dated October 31, 1986 as amended from time to time. |
|
| September 10, 2020 |
As filed with the Securities and Exchange Commission on September 10, 2020 Securities Act File No. |
|
| September 10, 2020 |
Notice of Change of Trustee, dated August 27, 2020(11) Exhibit (a)(xiii) TEKLA HEALTHCARE INVESTORS Amendment to Declaration of Trust Notice of Change of Trustee WHEREAS, by Action of Written Consent, the Trustees of Tekla Healthcare Investors (“The Fund”), the Trustees of the Fund appointed Jeffrey A. |
|
| September 10, 2020 |
Power of Attorney dated August 27, 2020(11) Exhibit (n)(ii) POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that Jeffrey A. |
|
| August 25, 2020 |
Tekla Healthcare Investors SCHEDULE OF INVESTMENTS June 30, 2020 Tekla Healthcare Investors SCHEDULE OF INVESTMENTS June 30, 2020 (Unaudited) SHARES VALUE CONVERTIBLE PREFERRED AND WARRANTS (Restricted) (a) (b) - 3. |
|
| May 8, 2020 |
Tekla Healthcare Investors Tekla Life Sciences Investors 100 Federal Street, 19th Floor Tekla Healthcare Opportunities Fund Boston, Massachusetts 02110 Tekla World Healthcare Fund Tel: (617) 772-8500 May 8, 2020 Via EDGAR Jeff Long U. |
|
| April 14, 2020 |
HQH / Tekla Healthcare Investors DEF 14A - - DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| February 27, 2020 |
TEKLA HEALTHCARE INVESTORS SCHEDULE OF INVESTMENTS DECEMBER 31, 2019 TEKLA HEALTHCARE INVESTORS SCHEDULE OF INVESTMENTS DECEMBER 31, 2019 (Unaudited) SHARES VALUE CONVERTIBLE PREFERRED AND WARRANTS(a) - 1. |
|
| August 29, 2019 |
HQH / Tekla Healthcare Investors NPORT-EX - - TEKLA HEALTHCARE INVESTORS SCHEDULE OF INVESTMENTS JUNE 30, 2019 (Unaudited) SHARES VALUE CONVERTIBLE PREFERRED AND WARRANTS(a) - 3. |
|
| June 20, 2019 |
Notice of Change of Trustee, dated June 13, 2019(9) Exhibit (a)(xii) TEKLA HEALTHCARE INVESTORS Amendment to Declaration of Trust Notice of Change of Trustee WHEREAS, Dr. |
|
| June 20, 2019 |
HQH / Tekla Healthcare Investors POS EX - - POST-EFFECTIVE AMENDMENT FILED SOLELY TO ADD EXHIBITS As filed with the Securities and Exchange Commission on June 20, 2019 Securities Act File No. |
|
| April 15, 2019 |
HQH / Tekla Healthcare Investors DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| March 12, 2019 |
Notice of Change of Trustee, dated December 13, 2018(8) Exhibit (a)(xi) TEKLA HEALTHCARE INVESTORS Amendment to Declaration of Trust Notice of Change of Trustee WHEREAS, Michael Bonney tendered his resignation as a Trustee of Tekla Healthcare Investors (the “Fund”) effective November 1, 2018, the Fund issues this notice in accordance with the terms of the Declaration of Trust of the Fund, dated and filed with the Secretary of State of the Commonwealth of Massachusetts on October 31, 1986, as amended; WHEREAS, at a meeting of the Trustees of Tekla Healthcare Investors (“the Fund”), the Trustees of the Fund appointed Dr. |
|
| March 12, 2019 |
Power of Attorney dated December 13, 2018(8) Exhibit (n)(ii) POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that Elizabeth G. |
|
| March 12, 2019 |
HQH / Tekla Healthcare Investors POST-EFFECTIVE AMENDMENT FILED SOLELY TO ADD EXHIBITS As filed with the Securities and Exchange Commission on March 12, 2019 Securities Act File No. |
|
| February 26, 2019 |
Tekla Healthcare Investors - N-Q OMB APPROVAL OMB Number: 3235-0578 Expires: March 31, 2019 UNITED STATES Estimated average burden hours per response . |
|
| February 26, 2019 |
EX-99.CERT 2 a19-21611ex99dcert.htm EX-99.CERT Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of Tekla Healthcare Investors; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under wh |
|
| August 28, 2018 |
Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of Tekla Healthcare Investors; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading w |
|
| August 28, 2018 |
HQH / Tekla Healthcare Investors N-Q (Quarterly Schedule of Portfolio Holdings) OMB APPROVAL OMB Number: 3235-0578 Expires: March 31, 2019 UNITED STATES Estimated average burden hours per response . |
|
| April 18, 2018 |
HQH / Tekla Healthcare Investors DEF 14A DEF 14A 1 a18-77151def14a.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as |
|
| April 18, 2018 |
Exhibit (k)(vi) Destra Capital Management LLC One North Wacker Drive 48th Floor Chicago, Illinois 60606 April 2, 2018 VIA EMAIL Tekla Funds 100 Federal Street, 19th Floor Boston, MA 02110 Re: Assignment/Written Consent Dear Laura Woodward: Due to an internal business matter, the management at Destra Capital Management LLC (“DCM”), the parent company of Destra Capital Investments LLC (“Destra”), ha |
|
| April 18, 2018 |
By-Laws of the Registrant, as amended (7) Exhibit (b) BY-LAWS OF TEKLA HEALTHCARE INVESTORS Revised through April 4, 2018 ARTICLE I Definitions The terms “Commission,” “Custodian,” “Declaration,” “Distributor,” “Investment Adviser,” “Majority Shareholder Vote,” “1940 Act,” “Shareholder,” “Shares,” “Transfer Agent,” “Trust,” “Trust Property” and “Trustees” have the respective meanings given them in the Amended and Restated Declaration of Trust of Tekla Healthcare Investors dated April 21, 1987 as amended from time to time. |
|
| April 18, 2018 |
Notice of Change of Trustee, dated December 20, 2017(7) Exhibit (a)(x) TEKLA HEALTHCARE INVESTORS Amendment to Declaration of Trust Notice of Change of Trustee WHEREAS, upon the death of Uwe E. |
|
| April 18, 2018 |
HQH / Tekla Healthcare Investors POST-EFFECTIVE AMENDMENT FILED SOLELY TO ADD EXHIBITS As filed with the Securities and Exchange Commission on April 18, 2018 Securities Act File No. |
|
| April 18, 2018 |
Power of Attorney dated April 9, 2018(7) Exhibit (n)(ii) POWER OF ATTORNEY KNOW ALL PERSONS BY THESE PRESENTS, that Thomas M. |
|
| February 23, 2018 |
Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of Tekla Healthcare Investors; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading w |
|
| February 23, 2018 |
Tekla Healthcare Investors - N-Q OMB APPROVAL OMB Number: 3235-0578 Expires: March 31, 2019 UNITED STATES Estimated average burden hours per response . |
|
| August 25, 2017 |
Tekla Healthcare Investors - N-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: March 31, 2019 Estimated average burden hours per response........10.5 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-04889 Tekla Healthcare Investors (Exact name of registrant as specified in chart |
|
| August 25, 2017 |
Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of Tekla Healthcare Investors; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading w |
|
| July 18, 2017 |
Tekla Healthcare Investors ESP CORRESP 1 filename1.htm Tekla Healthcare Investors 100 Federal Street, 19th Floor Tekla Life Sciences Investors Boston, Massachusetts 02110 Tekla Healthcare Opportunities Fund Tel: (617) 772-8500 July 18, 2017 VIA EDGAR Kathy Churko U.S. Securities and Exchange Commission Division of Investment Management Office of Disclosure Review and Accounting 100 F Street, NE Washington, DC 20549 Re: Tekla He |
|
| June 19, 2017 |
Exhibit (k)(v) SUPPORT SERVICES AGREEMENT This Agreement is made as of January 1, 2016, by and among Tekla World Healthcare Fund, Tekla Healthcare Opportunities Fund, Tekla Healthcare Investors and Tekla Life Sciences Investors, Massachusetts business trusts (together, the ?Tekla Funds? or the ?Funds?), and Destra Capital Investments LLC, a Delaware limited liability company (?Destra?). |
|
| June 19, 2017 |
Tekla Healthcare Investors POS EX As filed with the Securities and Exchange Commission on June 19, 2017 Securities Act File No. |
|
| June 19, 2017 |
Tekla Healthcare Investors ESP Tekla Healthcare Investors Tekla Life Sciences Investors 100 Federal Street, 19th Floor Tekla Healthcare Opportunities Fund Boston, Massachusetts 02110 Tel: (617) 772-8500 June 19, 2017 VIA EDGAR Kathy Churko U. |
|
| April 18, 2017 |
Tekla Healthcare Investors PRE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| February 24, 2017 |
Tekla Healthcare Investors - N-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: March 31, 2019 Estimated average burden hours per response........10.5 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-04889 Tekla Healthcare Investors (Exact name of registrant as specified in chart |
|
| February 24, 2017 |
Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of Tekla Healthcare Investors; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading w |
|
| August 26, 2016 |
Tekla Healthcare Investors N-Q (Quarterly Schedule of Portfolio Holdings) N-Q 1 a16-157451nq.htm N-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: March 31, 2019 Estimated average burden hours per response........10.5 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-04889 Tekla Healthcare Investors (Exact name of regis |
|
| August 26, 2016 |
Tekla Healthcare Investors N-Q (Quarterly Schedule of Portfolio Holdings) N-Q 1 a16-157451nq.htm N-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: March 31, 2019 Estimated average burden hours per response........10.5 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-04889 Tekla Healthcare Investors (Exact name of regis |
|
| August 26, 2016 |
EX-99.CERT 2 a16-157451ex99dcert.htm EX-99.CERT Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of Tekla Healthcare Investors; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under w |
|
| August 26, 2016 |
EX-99.CERT 2 a16-157451ex99dcert.htm EX-99.CERT Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of Tekla Healthcare Investors; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under w |
|
| April 18, 2016 |
Tekla Healthcare Investors DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| April 18, 2016 |
Tekla Healthcare Investors ESP One International Place, 40th Floor 100 Oliver Street Boston, MA 02110-2605 +1 617 728 7100 Main +1 617 426 6567 Fax www. |
|
| April 4, 2016 |
Tekla Healthcare Investors PRE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: x Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin |
|
| February 26, 2016 |
Tekla Healthcare Investors N-Q (Quarterly Schedule of Portfolio Holdings) N-Q 1 a16-17091nq.htm N-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: January 31, 2016 Estimated average burden hours per response........10.5 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-04889 Tekla Healthcare Investors (Exact name of regi |
|
| February 26, 2016 |
Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of Tekla Healthcare Investors; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading w |
|
| August 27, 2015 |
Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of Tekla Healthcare Investors; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading w |
|
| August 27, 2015 |
Tekla Healthcare Investors N-Q (Quarterly Schedule of Portfolio Holdings) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: January 31, 2016 Estimated average burden hours per response........10.5 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-04889 Tekla Healthcare Investors (Exact name of registrant as specified in cha |
|
| August 27, 2015 |
Tekla Healthcare Investors N-Q/A (Quarterly Schedule of Portfolio Holdings) UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: January 31, 2016 Estimated average burden hours per response........10.5 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-04889 Tekla Healthcare Investors (Exact name of registrant as specified in cha |
|
| August 27, 2015 |
Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of Tekla Healthcare Investors; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading w |
|
| April 20, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| February 26, 2015 |
EX-99.CERT 2 a15-12371ex99dcert.htm EX-99.CERT Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of Tekla Healthcare Investors; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under wh |
|
| February 26, 2015 |
Tekla Healthcare Investors - N-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: January 31, 2016 Estimated average burden hours per response........10.5 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-04889 Tekla Healthcare Investors (Exact name of registrant as specified in cha |
|
| August 27, 2014 |
HQH / Tekla Healthcare Investors N-Q - Quarterly Schedule of Portfolio Holdings - N-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: January 31, 2016 Estimated average burden hours per response........10.5 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-04889 H&Q Healthcare Investors (Exact name of registrant as specified in chart |
|
| August 27, 2014 |
EX-99.CERT 2 a14-185841ex99dcert.htm EX-99.CERT Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of H&Q Healthcare Investors; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under whi |
|
| July 21, 2014 |
HQH / Tekla Healthcare Investors CORRESP - - CORRESP 1 filename1.htm July 17, 2014 Ms. Christina DiAngelo Fettig Senior Staff Accountant Division of Investment Management Office of Disclosure Review U.S. Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Re: H&Q Healthcare Investors (SEC File Number: 811-4889) H&Q Life Sciences Investors (SEC File Number: 811-6565) Dear Ms. DiAngelo: This letter sets forth the responses |
|
| May 23, 2014 |
CORRESP 1 filename1.htm One International Place, 40th Floor 100 Oliver Street Boston, MA 02110 +1 617 728 7100 Main +1 617 275 8405 Fax www.dechert.com JOSEPH R. FLEMING [email protected] +1 617 728 7161 Direct +1 617 275 8392 Fax May 23, 2014 Stephanie D. Hui Division of Investment Management Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549-0504 Re: Registrati |
|
| April 30, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| February 24, 2014 |
Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of H&Q Healthcare Investors; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading wit |
|
| February 24, 2014 |
Quarterly Schedule of Portfolio Holdings - N-Q N-Q 1 a14-45611nq.htm N-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: January 31, 2016 Estimated average burden hours per response........10.5 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-04889 H&Q Healthcare Investors (Exact name of regist |
|
| August 23, 2013 |
EX-99.CERT 2 a13-179721ex99dcert.htm EX-99.CERT Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of H&Q Healthcare Investors; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under whi |
|
| August 23, 2013 |
Quarterly Schedule of Portfolio Holdings - N-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: January 31, 2016 Estimated average burden hours per response........10.5 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-04889 H&Q Healthcare Investors (Exact name of registrant as specified in chart |
|
| April 25, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| March 25, 2013 |
H&Q HEALTHCARE INVESTORS ANNOUNCES RENEWAL OF SHARE REPURCHASE PROGRAM Exhibit 99.1 FOR IMMEDIATE RELEASE H&Q HEALTHCARE INVESTORS ANNOUNCES RENEWAL OF SHARE REPURCHASE PROGRAM BOSTON, MA, March 22, 2013 — H&Q Healthcare Investors (NYSE: HQH) (the “Fund”) announced today that the Board of Trustees authorized a renewal of its share repurchase program. The current share repurchase program allows the Fund to purchase in the open market up to 12% of its outstanding commo |
|
| March 25, 2013 |
Financial Statements and Exhibits, Other Events 8-K 1 a13-828918k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 22, 2013 H&Q HEALTHCARE INVESTORS (Exact name of Registrant as specified in its charter) Massachusetts (State or other jurisdiction of incorporation) 8 |
|
| February 22, 2013 |
Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of H&Q Healthcare Investors; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading wit |
|
| February 22, 2013 |
Quarterly Schedule of Portfolio Holdings - N-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: April 30, 2013 Estimated average burden hours per response........5.6 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-04889 H&Q Healthcare Investors (Exact name of registrant as specified in charter) |
|
| August 28, 2012 |
Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of H&Q Healthcare Investors; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading wit |
|
| August 28, 2012 |
Quarterly Schedule of Portfolio Holdings - N-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: April 30, 2013 Estimated average burden hours per response........5.6 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-04889 H&Q Healthcare Investors (Exact name of registrant as specified in charter) |
|
| August 2, 2012 |
August 2, 2012 Ms. Christina DiAngelo Senior Staff Accountant Division of Investment Management Office of Disclosure Review U.S. Securities and Exchange Commission 100 F Street, NE Washington, DC 20549 Re: H&Q Healthcare Investors (SEC File Number: 811-4889) H&Q Life Sciences Investors (SEC File Number: 811-6565) Dear Ms. DiAngelo: This letter sets forth the responses of H&Q Healthcare Investors ( |
|
| May 18, 2012 |
DEFA14A 1 a12-124571defa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (a |
|
| May 8, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin |
|
| April 30, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| March 23, 2012 |
H&Q HEALTHCARE INVESTORS ANNOUNCES RENEWAL OF SHARE REPURCHASE PROGRAM Exhibit 99.1 FOR IMMEDIATE RELEASE H&Q HEALTHCARE INVESTORS ANNOUNCES RENEWAL OF SHARE REPURCHASE PROGRAM BOSTON, MA, March 23, 2012 — H&Q Healthcare Investors (NYSE: HQH) (the “Fund”) announced today that the Board of Trustees authorized a renewal of its share repurchase program. The current share repurchase program allows the Fund to purchase in the open market up to 12% of its outstanding commo |
|
| March 23, 2012 |
Financial Statements and Exhibits, Other Events - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 23, 2012 H&Q HEALTHCARE INVESTORS (Exact name of Registrant as specified in its charter) Massachusetts (State or other jurisdiction of incorporation) 811-04889 04-6564285 (Commi |
|
| February 28, 2012 |
Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of H&Q Healthcare Investors; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading wit |
|
| February 28, 2012 |
Quarterly Schedule of Portfolio Holdings - N-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: April 30, 2013 Estimated average burden hours per response........5.6 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-04889 H&Q Healthcare Investors (Exact name of registrant as specified in charter) |
|
| August 22, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: April 30, 2013 Estimated average burden hours per response........5.6 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-04889 H&Q Healthcare Investors (Exact name of registrant as specified in charter) |
|
| August 22, 2011 |
Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of H&Q Healthcare Investors; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading wit |
|
| July 8, 2011 |
H&Q HEALTHCARE INVESTORS ANNOUNCES APPROVAL OF DECLARATION AMENDMENT Exhibit 99.1 H&Q HEALTHCARE INVESTORS ANNOUNCES APPROVAL OF DECLARATION AMENDMENT BOSTON, MA, July 8, 2011—H&Q Healthcare Investors (NYSE: HQH) (the “Fund”) announced today that the Fund’s shareholders approved an amendment to the Fund’s Amended and Restated Declaration of Trust (the “Declaration Amendment”) at its annual meeting. The Declaration Amendment removes certain limitations on the Truste |
|
| July 8, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 8, 2011 H&Q HEALTHCARE INVESTORS (Exact name of Registrant as specified in its charter) Massachusetts (State or other jurisdiction of incorporation) 811-04889 04-6564285 (Commiss |
|
| June 30, 2011 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 30, 2011 H&Q HEALTHCARE INVESTORS (Exact name of Registrant as specified in its charter) Massachusetts (State or other jurisdiction of incorporation) 811-04889 04-6564285 (Commis |
|
| June 30, 2011 |
H&Q HEALTHCARE INVESTORS ANNOUNCES SHARE REPURCHASE PROGRAM Exhibit 99.1 FOR IMMEDIATE RELEASE H&Q HEALTHCARE INVESTORS ANNOUNCES SHARE REPURCHASE PROGRAM BOSTON, MA, June 30, 2011 — H&Q Healthcare Investors (NYSE: HQH) (the “Fund”) announced today that the Board of Trustees authorized a share repurchase program. The program will allow the Fund to purchase in the open market up to 12% of its outstanding common shares for a one year period beginning July 11 |
|
| June 8, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| May 20, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: ý Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) o Defin |
|
| February 28, 2011 |
Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of H&Q Healthcare Investors; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading wit |
|
| February 28, 2011 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: April 30, 2013 Estimated average burden hours per response........5.6 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-04889 H&Q Healthcare Investors (Exact name of registrant as specified in charter) |
|
| November 2, 2010 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 1, 2010 H&Q HEALTHCARE INVESTORS (Exact name of Registrant as specified in its charter) Massachusetts (State or other jurisdiction of incorporation) 811-04889 04-6564285 (Com |
|
| November 2, 2010 |
H&Q HEALTHCARE INVESTORS ANNOUNCES INCREASE OF DISTRIBUTION RATE UNDER MANAGED DISTRIBUTION POLICY Exhibit 99.1 FOR IMMEDIATE RELEASE H&Q HEALTHCARE INVESTORS ANNOUNCES INCREASE OF DISTRIBUTION RATE UNDER MANAGED DISTRIBUTION POLICY BOSTON, MA, November 1, 2010 — H&Q Healthcare Investors announced today that it will increase the rate it pays pursuant to its managed distribution policy (the “Policy”) to 2% of net assets each quarter, up from the previous distribution rate of 1.25% each quarter. |
|
| August 27, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: March 31, 2012 Estimated average burden hours per response........9.6 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-04889 H&Q Healthcare Investors (Exact name of registrant as specified in charter) |
|
| August 27, 2010 |
Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of H&Q Healthcare Investors; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading wit |
|
| April 27, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| April 6, 2010 |
Exhibit 99.1 FOR IMMEDIATE RELEASE H&Q HEALTHCARE INVESTORS ANNOUNCES REINSTATEMENT OF DISTRIBUTION UNDER MANAGED DISTRIBUTION POLICY BOSTON, MA, April 5, 2010 — H&Q Healthcare Investors announced today the reinstatement of distributions pursuant to its managed distribution policy (the “Policy”). The Policy will provide for quarterly distributions at an annualized rate equal to 5% of net assets. T |
|
| April 6, 2010 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 5, 2010 H&Q HEALTHCARE INVESTORS (Exact name of Registrant as specified in its charter) Massachusetts (State or other jurisdiction of incorporation) 811-04889 04-6564285 (Commis |
|
| March 1, 2010 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: April 30, 2010 Estimated average burden hours per response........10.5 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-04889 H&Q Healthcare Investors (Exact name of registrant as specified in charter |
|
| March 1, 2010 |
Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of H&Q Healthcare Investors; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading wit |
|
| September 30, 2009 |
Exhibit 99.1 FOR IMMEDIATE RELEASE Exhibit 99.1 FOR IMMEDIATE RELEASE H&Q HEALTHCARE INVESTORS ANNOUNCES SHARE REPURCHASE PROGRAM BOSTON, MA, September 30, 2009 — H&Q Healthcare Investors (NYSE: HQH) announced today that the Board of Trustees authorized a share repurchase program. The program will allow the Fund to purchase in the open market up to 10% of its outstanding common shares for a one year period beginning October 9, 2009 |
|
| September 30, 2009 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 30, 2009 H&Q HEALTHCARE INVESTORS (Exact name of Registrant as specified in its charter) Massachusetts (State or other jurisdiction of incorporation) 811-04889 04-6564285 (C |
|
| August 28, 2009 |
Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of H&Q Healthcare Investors; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading wit |
|
| August 28, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: April 30, 2010 Estimated average burden hours per response........10.5 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-04889 H&Q Healthcare Investors (Exact name of registrant as specified in charter |
|
| August 4, 2009 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 4, 2009 H&Q HEALTHCARE INVESTORS (Exact name of Registrant as specified in its charter) Massachusetts (State or other jurisdiction of incorporation) 811-04889 04-6564285 (Commi |
|
| August 4, 2009 |
EX-99.1 2 a09-203861ex99d1.htm EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE H&Q HEALTHCARE INVESTORS ANNOUNCES SUSPENSION OF DISTRIBUTION POLICY BOSTON, MA, August 4, 2009 — H&Q Healthcare Investors announced today that it will suspend its managed distribution policy (the “Policy”) and payment of quarterly distributions until further notice. The suspension of the Policy is effective immediately. As |
|
| May 1, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| March 2, 2009 |
EX-99.CERT 2 a09-46221ex99dcert.htm EX-99.CERT Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of H&Q Healthcare Investors; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under whic |
|
| March 2, 2009 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: April 30, 2010 Estimated average burden hours per response........10.5 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-04889 H&Q Healthcare Investors (Exact name of registrant as specified in charter |
|
| August 28, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: April 30, 2010 Estimated average burden hours per response........10.5 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-04889 H&Q Healthcare Investors (Exact name of registrant as specified in charter |
|
| August 28, 2008 |
Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of H&Q Healthcare Investors; 2. Based on my knowledge, this report does not contain any untrue statement of material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with |
|
| July 18, 2008 |
– The Board of Trustees of H&Q Healthcare Investors Adopts Amendments to the By-laws of the Fund Exhibit 99.1 07/18/2008 ? The Board of Trustees of H&Q Healthcare Investors Adopts Amendments to the By-laws of the Fund On July 17, 2008, the Board of Trustees of H&Q Healthcare Investors (the ?Fund?) adopted amendments to the By-laws of the Fund. The Trustees determined that the By-laws should be updated in order to ensure an orderly and informed shareholder meeting process for all participating |
|
| July 18, 2008 |
Financial Statements and Exhibits, Other Events 8-K 1 a08-1946718k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 18, 2008 H&Q HEALTHCARE INVESTORS (Exact name of Registrant as specified in its charter) Massachusetts (State or other jurisdiction of incorporation) 8 |
|
| May 5, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) x Defin |
|
| February 29, 2008 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: April 30, 2010 Estimated average burden hours per response........10.5 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-04889 H&Q Healthcare Investors (Exact name of registrant as specified in charter |
|
| February 29, 2008 |
Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of H&Q Healthcare Investors; 2. Based on my knowledge, this report does not contain any untrue statement of material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with |
|
| August 29, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: April 30, 2010 Estimated average burden hours per response........10.5 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-04889 H&Q Healthcare Investors (Exact name of registrant as specified in charter |
|
| August 29, 2007 |
Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of H&Q Healthcare Investors; 2. Based on my knowledge, this report does not contain any untrue statement of material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with |
|
| May 10, 2007 |
UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0059 Washington, D. |
|
| April 5, 2007 |
UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0059 Washington, D. |
|
| March 1, 2007 |
EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of H&Q Healthcare Investors; 2. Based on my knowledge, this report does not contain any untrue statement of material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the p |
|
| March 1, 2007 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: May 31, 2007 Estimated average burden hours per response........21.09 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-04889 H&Q Healthcare Investors (Exact name of registrant as specified in charter) |
|
| August 29, 2006 |
Exhibit 99CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of H&Q Healthcare Investors; 2. Based on my knowledge, this report does not contain any untrue statement of material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with r |
|
| August 29, 2006 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: May 31, 2007 Estimated average burden hours per response........21.09 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-06565 H&Q Healthcare Investors (Exact name of registrant as specified in charter) |
|
| May 8, 2006 |
UNITED STATES OMB APPROVAL SECURITIES AND EXCHANGE COMMISSION OMB Number: 3235-0059 Washington, D. |
|
| February 28, 2006 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: May 31, 2007 Estimated average burden hours per response........21.09 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-06565 H&Q Healthcare Investors (Exact name of registrant as specified in charter) |
|
| February 28, 2006 |
Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of H&Q Healthcare Investors; 2. Based on my knowledge, this report does not contain any untrue statement of material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with |
|
| August 26, 2005 |
EX-99.CERT 2 a05-151771ex99dcert.htm EX-99.CERT Exhibit 99.CERT EXHIBIT 1 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of H&Q Healthcare Investors; 2. Based on my knowledge, this report does not contain any untrue statement of material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which |
|
| August 26, 2005 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: February 28, 2006 Estimated average burden hours per response........20.00 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-06565 H&Q Healthcare Investors (Exact name of registrant as specified in cha |
|
| May 16, 2005 |
OMB Approval OMB Number: 3235-0145 Expires: December 31, 2005 Estimated average burden Hours per response. |
|
| March 1, 2005 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 OMB APPROVAL OMB Number: 3235-0578 Expires: February 28, 2006 Estimated average burden hours per response........20.00 FORM N-Q QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED MANAGEMENT INVESTMENT COMPANY Investment Company Act file number 811-06565 H&Q Healthcare Investors (Exact name of registrant as specified in cha |
|
| March 1, 2005 |
Fund Name Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 Exhibit 99.CERT Fund Name Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 CERTIFICATIONS I, Daniel Omstead, certify that: 1. I have reviewed this report on Form N-Q of H&Q Healthcare Investors; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the |
